These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

203 related articles for article (PubMed ID: 9292906)

  • 1. Dornase alpha in the management of a mechanically ventilated infant with cystic fibrosis.
    Kling S; Gie RP; Riphagen S
    Pediatr Pulmonol; 1997 Aug; 24(2):124-5. PubMed ID: 9292906
    [No Abstract]   [Full Text] [Related]  

  • 2. What is the cystic fibrosis clinician supposed to do with human recombinant dornase alfa?
    Coates AL
    J Pediatr; 2001 Dec; 139(6):768-70. PubMed ID: 11743499
    [No Abstract]   [Full Text] [Related]  

  • 3. Advances in the treatment of cystic fibrosis.
    Hopkins S
    Nurs Times; 1995 Sep 27-Oct 3; 91(39):40-1. PubMed ID: 7567556
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Current therapeutic agents: dornase alfa].
    Baran D; Sternon J
    Rev Med Brux; 1997 Feb; 18(1):37-40. PubMed ID: 9132917
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dornase alfa: a new option in the management of cystic fibrosis.
    Witt DM; Anderson L
    Pharmacotherapy; 1996; 16(1):40-8. PubMed ID: 8700791
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Aerosolized deoxyribonuclease for cystic fibrosis.
    Med Lett Drugs Ther; 1994 Apr; 36(920):34-5. PubMed ID: 8145672
    [No Abstract]   [Full Text] [Related]  

  • 7. [Cystic fibrosis. Current indications for nebulized treatments: antibiotics and DNase].
    Sardet-Frismand A
    Rev Mal Respir; 1999 Jan; 16 Suppl 3():S131-2. PubMed ID: 10088286
    [No Abstract]   [Full Text] [Related]  

  • 8. [Swiss registry for patients with cystic fibrosis: design, programming, implementation and first examples of use].
    Schöni-Affolter F; Oswald P; Wandt-Baumann C; Kriemler S; Schöni MH
    Schweiz Med Wochenschr; 2000 Sep; 130(39):1373-81. PubMed ID: 11059028
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Early treatment with dornase alfa in cystic fibrosis: what are the issues?
    Bush A
    Pediatr Pulmonol; 1998 Feb; 25(2):79-82. PubMed ID: 9516089
    [No Abstract]   [Full Text] [Related]  

  • 10. Dornase alfa as postoperative therapy in cystic fibrosis sinonasal disease.
    Cimmino M; Nardone M; Cavaliere M; Plantulli A; Sepe A; Esposito V; Mazzarella G; Raia V
    Arch Otolaryngol Head Neck Surg; 2005 Dec; 131(12):1097-101. PubMed ID: 16365224
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A two-year randomized, placebo-controlled trial of dornase alfa in young patients with cystic fibrosis with mild lung function abnormalities.
    Quan JM; Tiddens HA; Sy JP; McKenzie SG; Montgomery MD; Robinson PJ; Wohl ME; Konstan MW;
    J Pediatr; 2001 Dec; 139(6):813-20. PubMed ID: 11743506
    [TBL] [Abstract][Full Text] [Related]  

  • 12. USAN Council. List No.405. New names. Dornase alfa.
    Clin Pharmacol Ther; 1998 Jun; 63(6):705. PubMed ID: 9687230
    [No Abstract]   [Full Text] [Related]  

  • 13. Dornase alpha and survival of patients with cystic fibrosis.
    McIntyre AM
    Hosp Med; 1999 Oct; 60(10):736-9. PubMed ID: 10656067
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dornase alfa therapy in cystic fibrosis: who should get it?
    Kanga JF
    Chest; 1996 Oct; 110(4):871-2. PubMed ID: 8874235
    [No Abstract]   [Full Text] [Related]  

  • 15. Dornase-alfa (DNase, Pulmozyme) for cystic fibrosis.
    MacConnachie AM
    Intensive Crit Care Nurs; 1998 Apr; 14(2):101-2. PubMed ID: 9814214
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The use of recombinant human dornase alfa in CF.
    Cox C
    Paediatr Nurs; 1995 Nov; 7(9):29-31. PubMed ID: 8705343
    [No Abstract]   [Full Text] [Related]  

  • 17. Dornase in treatment of chronic bronchitis.
    Hudson TJ
    Ann Pharmacother; 1996 Jun; 30(6):674-5. PubMed ID: 8792955
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Recombinant human deoxyribonuclease shortens ventilation time in young, mechanically ventilated children.
    Riethmueller J; Borth-Bruhns T; Kumpf M; Vonthein R; Wiskirchen J; Stern M; Hofbeck M; Baden W
    Pediatr Pulmonol; 2006 Jan; 41(1):61-6. PubMed ID: 16265663
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The overuse or underuse of dornase alfa.
    Shah PL; Hodson ME
    Curr Opin Pulm Med; 1997 Nov; 3(6):410-3. PubMed ID: 9391759
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [2 significant stages in the management of mucoviscidosis: the French experience with dornase alfa (Pulmozyme) and the impact in international registries].
    Brémont F; Navarro J
    Arch Pediatr; 1998 Apr; 5(4):367-70. PubMed ID: 9759154
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 11.